Funded by a grant from the Bill and Melinda Gates Foundation, The Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center created the CEVR Global Health CEA (GH CEA) registry, a database of cost-effectiveness analysis (CEA) studies that evaluate health interventions from around the world. The Global Health CEA registry focuses on those interventions designed to mitigate disease burden in countries at various stages of industrial development.
The Global Health Cost Effectiveness Analysis (GH CEA) Registry is a free database that compiles research literature on the economic value of global health interventions. Our inclusion criterion for contributing articles is contingent on its application of the “cost-per-DALY-averted” metric, which measures the cost-effectiveness of an intervention.
The GH CEA Registry is a repository of all peer-reviewed cost-per-DALY studies stratified by methods, cost-per-DALY ratios, and disability weights published since the 1990s.
Global health organizations acknowledge the importance of prioritizing limited health care resources, but the question remains: are we spending our money wisely? Cost-effectiveness analysis can help stakeholders gain a better understanding of the return on investment of global health interventions and has the potential to inform smart investments and maximize the impact on population health.
- Global Burden of Disease Classification & ICD-10
- Primary, Secondary & Tertiary Prevention Classification
- Funding Source
- Study Perspective
- Target Population
- Intervention & Comparator
- Costs & DALYs
- Incremental Cost-Effectiveness Ratio (ICER)
- Disability Weight